<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art560.dtd?><?SourceDTD.Version 5.6.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_JBC105507 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?FILEgr3 jpg ?><?FILEgr4 jpg ?><?FILEmmc1 pdf ?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id><journal-id journal-id-type="iso-abbrev">J Biol Chem</journal-id><journal-title-group><journal-title>The Journal of Biological Chemistry</journal-title></journal-title-group><issn pub-type="ppub">0021-9258</issn><issn pub-type="epub">1083-351X</issn><publisher><publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmcid">10776993</article-id><article-id pub-id-type="pii">S0021-9258(23)02535-8</article-id><article-id pub-id-type="doi">10.1016/j.jbc.2023.105507</article-id><article-id pub-id-type="publisher-id">105507</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Characterization of the cystargolide biosynthetic gene cluster and functional analysis of the methyltransferase CysG</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Beller</surname><given-names>Patrick</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Fink</surname><given-names>Phillipp</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>Wolf</surname><given-names>Felix</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au4"><name><surname>M&#x000e4;nnle</surname><given-names>Daniel</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au5"><name><surname>Helmle</surname><given-names>Irina</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au6"><name><surname>Kuttenlochner</surname><given-names>Wolfgang</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author" id="au7"><name><surname>Unterfrauner</surname><given-names>Daniel</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au8"><name><surname>Engelbrecht</surname><given-names>Alicia</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au9"><name><surname>Staudt</surname><given-names>Nicole D.</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au10"><name><surname>Kulik</surname><given-names>Andreas</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author" id="au11"><name><surname>Groll</surname><given-names>Michael</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author" id="au12"><name><surname>Gross</surname><given-names>Harald</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au13"><name><surname>Kaysser</surname><given-names>Leonard</given-names></name><email>leonard.kaysser@uni-leipzig.de</email><xref rid="aff4" ref-type="aff">4</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><aff id="aff1"><label>1</label>Department of Pharmaceutical Biology, Pharmaceutical Institute, University of T&#x000fc;bingen, T&#x000fc;bingen, Germany</aff><aff id="aff2"><label>2</label>Department of Bioscience, Center for Protein Assemblies (CPA), TUM School of Natural Sciences, Technical University of Munich, Garching, Germany</aff><aff id="aff3"><label>3</label>Interfaculty Institute for Microbiology and Infection Medicine T&#x000fc;bingen (IMIT), Microbial Bioactive Compounds, University of T&#x000fc;bingen, T&#x000fc;bingen, Germany</aff><aff id="aff4"><label>4</label>Department of Pharmaceutical Biology, Institute for Drug Discovery, University of Leipzig, Leipzig, Germany</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>For correspondence: Leonard Kaysser <email>leonard.kaysser@uni-leipzig.de</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>27</day><month>11</month><year>2023</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><month>1</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>11</month><year>2023</year></pub-date><volume>300</volume><issue>1</issue><elocation-id>105507</elocation-id><history><date date-type="received"><day>24</day><month>7</month><year>2023</year></date><date date-type="rev-recd"><day>17</day><month>11</month><year>2023</year></date></history><permissions><copyright-statement>&#x000a9; 2023 The Authors</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><p>Cystargolides are natural products originally isolated from <italic>Kitasatospora cystarginea</italic> NRRL B16505 as inhibitors of the proteasome. They are composed of a dipeptide backbone linked to a &#x003b2;-lactone warhead. Recently, we identified the cystargolide biosynthetic gene cluster, but systematic genetic analyses had not been carried out because of the lack of a heterologous expression system. Here, we report the discovery of a homologous cystargolide biosynthetic pathway in <italic>Streptomyces durhamensis</italic> NRRL-B3309 by genome mining. The gene cluster was cloned <italic>via</italic> transformation-associated recombination and heterologously expressed in <italic>Streptomyces coelicolor</italic> M512. We demonstrate that it contains all genes necessary for the production of cystargolide A and B. Single gene deletion experiments reveal that only five of the eight genes from the initially proposed gene cluster are essential for cystargolide synthesis. Additional insights into the cystargolide pathway could be obtained from <italic>in&#x000a0;vitro</italic> assays with CysG and chemical complementation of the respective gene knockout. This could be further supported by the <italic>in&#x000a0;vitro</italic> investigation of the CysG homolog BelI from the belactosin biosynthetic gene cluster. Thereby, we confirm that CysG and BelI catalyze a cryptic SAM-dependent transfer of a methyl group that is critical for the construction of the cystargolide and belactosin &#x003b2;-lactone warheads.</p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>natural product</kwd><kwd>lactone</kwd><kwd>proteasome</kwd><kwd>inhibitor</kwd><kwd>biosynthesis</kwd><kwd>gene knockout</kwd><kwd>heterologous expression</kwd></kwd-group></article-meta><def-list><title>Abbreviations</title><def-item><term id="kwrd0050">BGC</term><def><p>biosynthetic gene cluster</p></def></def-item><def-item><term id="kwrd0060">EIC</term><def><p>extracted ion chromatogram</p></def></def-item><def-item><term id="kwrd0070">HPLC-MS</term><def><p>high performance liquid chromatography mass spectrometry</p></def></def-item><def-item><term id="kwrd0080">IPM</term><def><p>Isopropylmalate</p></def></def-item><def-item><term id="kwrd0090">IPMS</term><def><p>Isopropylmalate synthase</p></def></def-item><def-item><term id="kwrd0100">MS/MS</term><def><p>tandem mass spectrometry</p></def></def-item><def-item><term id="kwrd0110">NRPS</term><def><p>non-ribosomal peptide synthetase</p></def></def-item><def-item><term id="kwrd0120">PKS</term><def><p>polyketide synthetase</p></def></def-item><def-item><term id="kwrd0130">TAR</term><def><p>transformation associated recombination</p></def></def-item><def-item><term id="kwrd0140">TIC</term><def><p>total ion chromatogram</p></def></def-item><def-item><term id="kwrd0150">SAM</term><def><p>S-adenosyl methionine</p></def></def-item><def-item><term id="kwrd0160">sBM</term><def><p>3-<italic>sec</italic>-butyl malate</p></def></def-item></def-list><notes><p id="misc0010">Reviewed by members of the JBC Editorial Board. Edited by Sarah E. O'Connor</p></notes></front><body><p id="p0010">The proteasome is the central component in non-lysosomal protein degradation (<xref rid="bib1" ref-type="bibr">1</xref>, <xref rid="bib2" ref-type="bibr">2</xref>). It plays a vital role in a multitude of cellular processes, such as cell cycle control (<xref rid="bib3" ref-type="bibr">3</xref>), apoptosis (<xref rid="bib4" ref-type="bibr">4</xref>), and immune response (<xref rid="bib5" ref-type="bibr">5</xref>). The multi-subunit protein complex is associated with various diseases including neurodegenerative (<xref rid="bib6" ref-type="bibr">6</xref>, <xref rid="bib7" ref-type="bibr">7</xref>) or cardiovascular disorders (<xref rid="bib8" ref-type="bibr">8</xref>) and different types of cancers (<xref rid="bib9" ref-type="bibr">9</xref>). Consequently, the proteasome is a validated target for the development of small-molecule pharmaceutics. Most of these are designed to covalently bind the catalytic subunits and inactivate the active site in a reversible or irreversible manner (<xref rid="bib10" ref-type="bibr">10</xref>). Cystargolides A and B were originally isolated from <italic>Kitasatospora cystarginea</italic> NRRL B16505 and were found to inhibit the human proteasome and the caseinolytic protease ClpP in the micromolar range (<xref rid="bib11" ref-type="bibr">11</xref>,&#x000a0;<xref rid="bib12" ref-type="bibr">12</xref>, <xref rid="bib13" ref-type="bibr">13</xref>). The cystargolides feature a &#x003b2;-lactone warhead and a dipeptide backbone similar to the well-characterized belactosins (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>). Belactosins A and C are produced by <italic>Streptomyces</italic> sp. UCK 14 and, in analogy to the cystargolides, primarily block the function of the chymotrypsin-like &#x003b2;5 subunit of the 20S proteasome (<xref rid="bib14" ref-type="bibr">14</xref>, <xref rid="bib15" ref-type="bibr">15</xref>). Notably, many &#x003b2;-lactone-containing secondary metabolites are synthesized by non-ribosomal peptide synthetases (NRPSs) or polyketide synthases (PKSs) (<xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib17" ref-type="bibr">17</xref>). We recently identified the cystargolide biosynthetic gene cluster (BGC) and constructed gene disruption mutants in <italic>K.&#x000a0;cystarginea</italic> NRRL B16505 (<xref rid="bib18" ref-type="bibr">18</xref>). This revealed that the cystargolide and belactosin formation does not involve NRPS or PKS machinery but proceeds <italic>via</italic> single enzyme amino acid ligases. Intriguingly, the route to the carbon scaffold of their &#x003b2;-lactone warheads is reminiscent of leucine biosynthesis. Here, we present a homologous cystargolide BGC from <italic>Streptomyces durhamensis</italic> NRRL-B3309. The gene cluster was cloned <italic>via</italic> transformation-associated recombination (TAR) and heterologously expressed in <italic>Streptomyces coelicolor</italic> M512 allowing a systematic set of gene knockouts to investigate the functions of the encoded proteins.<fig id="fig1"><label>Figure&#x000a0;1</label><caption><p><bold>Chemical structure of cystargolides and belactosins</bold>.</p></caption><graphic xlink:href="gr1"/></fig></p><sec id="sec1"><title>Results</title><p id="p0015">In order to characterize the biosynthetic pathway of the cystargolides, we attempted to heterologously express the BGC we identified in <italic>K.&#x000a0;cystarginea</italic> NRRL B16505 (<xref rid="bib18" ref-type="bibr">18</xref>). However, this pathway could not be stably introduced in various <italic>Streptomyces</italic> strains.</p><sec id="sec1.1"><title>Identification and heterologous expression of a homologous cystargolide pathway in <italic>Streptomyces</italic></title><p id="p0020">Using MultiGeneBLAST, we discovered a homologous putative cystargolide (<italic>cys</italic>) BGC in <italic>S.&#x000a0;durhamensis</italic> NRRL-B3309 (<xref rid="bib19" ref-type="bibr">19</xref>). This pathway differs only marginally from the one found in <italic>K.&#x000a0;cystarginea</italic> NRRL B16505, with all eight genes showing sequence identities between 63% and 83% to their respective homologs (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>; <xref rid="appsec1" ref-type="sec">Table&#x000a0;S1</xref>). Organizationally, only the orientation of <italic>cysH</italic> in <italic>S.&#x000a0;durhamensis</italic> NRRL-B3309 is inverted compared to <italic>K.&#x000a0;cystarginea</italic> NRRL B16505. To confirm the identity of this BGC, the cluster was captured with a pCAP03-derived vector using TAR-based direct cloning technologies (<xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S3</xref>) (<xref rid="bib20" ref-type="bibr">20</xref>, <xref rid="bib21" ref-type="bibr">21</xref>, <xref rid="bib22" ref-type="bibr">22</xref>). Therefore, pCAP03 was linearized and equipped with 299&#x000a0;bp extensions on both ends which contained homologous sequences up- and downstream the putative <italic>cys</italic> BGC. Co-transformation of <italic>Saccharomyces cerevisiae</italic> with the capture vector and digested genomic DNA from <italic>S.&#x000a0;durhamensis</italic> resulted in the cloning of a 10,809&#x000a0;bp stretch of DNA that contained the complete putative <italic>cys</italic> BGC as verified by PCR and restriction analysis. Subsequently, the generated cysDM02-construct was introduced into <italic>S.&#x000a0;coelicolor</italic> M512 <italic>via</italic> triparental mating and stably integrated into the genome taking advantage of the &#x003c6;C31 integration site.<fig id="fig2"><label>Figure&#x000a0;2</label><caption><p><bold>The cystargolide biosynthetic gene cluster from <italic>K.&#x000a0;cystarginea</italic> NRRL-B16505 (<italic>top</italic>), <italic>S.&#x000a0;durhamensis</italic> NRRL-B3309 (<italic>middle</italic>), and the belactosin biosynthetic gene cluster from <italic>St</italic></bold><bold><italic>r</italic></bold><bold><italic>ep</italic></bold><bold><italic>tomyces</italic> sp. UCK 14 (<italic>bottom</italic>).</bold> The individual genes are colored according to their putative biosynthetic function. Homologous genes in the cystargolide and belactosin BGCs are indicated.</p></caption><graphic xlink:href="gr2"/></fig></p><p id="p0025">Three individual clones were checked by PCR for the presence of the <italic>cys</italic> BGC, designated <italic>S.&#x000a0;coelicolor</italic> M512/cysDM02 I-III, and selected for further investigations. Therefore, cells were cultivated in liquid cultures of SM1 medium for 7&#x000a0;days followed by crude extraction with ethyl acetate (EtOAc). A first screening approach revealed the specific activity of extracts from mutants containing the homologous <italic>cys</italic> pathway in a human proteasome inhibition assay (<xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S5</xref>). Next, the metabolic profiles of the mutants were analyzed by high-performance liquid chromatography coupled with electrospray ionization mass spectrometry (HPLC-ESI-MS). Gratifyingly, the characteristic mass signals of cystargolide A (<italic>m/z</italic> 357.2 [M&#x000a0;+ H]<sup>+</sup>) and cystargolide B (<italic>m/z</italic> 371.2 [M&#x000a0;+ H]<sup>+</sup>) were detected at retention times of 10.2 and 9.5&#x000a0;min, respectively (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref>). Similar ions could not be found in extracts of <italic>S.&#x000a0;coelicolor</italic> M512 without the gene cluster. Moreover, tandem mass spectrometry (MS/MS) revealed characteristic fragmentation patterns for the produced compounds (<xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S10</xref>) identical to cystargolide A and B (<xref rid="bib18" ref-type="bibr">18</xref>). This confirms that the isolated BGC from <italic>S.&#x000a0;durhamensis</italic> NRRL-B3309 contains all genes necessary for the synthesis of cystargolides.<fig id="fig3"><label>Figure&#x000a0;3</label><caption><p><bold>LC-MS analysis of culture crude extracts from the heterologous host strain <italic>S.&#x000a0;coelicolor</italic> M512 containing the cystargolide BGC from <italic>S.&#x000a0;durhamensis</italic> NRRL-B3309 and its knockout variants compared to <italic>S.&#x000a0;coelicolor</italic> M512 wild type.</bold> The retention time of cystargolide B: t&#x000a0;= 9.5&#x000a0;min, cystargolide A: t&#x000a0;= 10.2&#x000a0;min. <italic>A</italic>, total ion chromatograms (TIC), cystargolide peaks are highlighted. <italic>B</italic>, extracted ion chromatograms (EIC) of cystargolide B&#x000a0;<italic>m/z</italic> 357.2 [M&#x000a0;+ H]<sup>+</sup> and cystargolide A&#x000a0;<italic>m/z</italic> 371.2 [M&#x000a0;+ H]<sup>+</sup>, the peaks are normalized to the highest intensity.</p></caption><graphic xlink:href="gr3"/></fig></p></sec><sec id="sec1.2"><title>Generation and analysis of gene deletion mutants</title><p id="p0030">In order to determine the function of the clustered genes, single-gene knockout variants of the <italic>cys</italic> BGC were heterologously expressed in <italic>S.&#x000a0;coelicolor</italic> M512. Therefore, the genes were individually replaced with an apramycin resistance cassette using the PCR-targeting system (<xref rid="bib23" ref-type="bibr">23</xref>). Unmarked in-frame gene deletions were generated by excision of the resistance cassettes, taking advantage of the flanking FLP recombination target (FRT) sites. <italic>S.&#x000a0;coelicolor</italic> M512 derivatives containing the modified gene clusters were cultivated and analyzed by LC-MS. This revealed that cystargolide production was not impacted in the knockout mutants with &#x00394;<italic>cysA</italic> and &#x00394;<italic>cysB</italic> (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref>). Interestingly, the gene <italic>cysA</italic> codes for an isopropylmalate synthase-homolog and is likely to be involved in the formation of 2-isopropylmalate (2-IPM) from acetyl-CoA and &#x003b1;-ketoisovalerate. Isopropylmalate synthases (IPMS) are essential for <italic>de novo</italic> leucine biosynthesis and are a central part of the bacterial primary metabolism. Therefore, the loss of <italic>cysA</italic> might be complemented by the house-keeping IPMS homolog from the host organism. Indeed, a BLAST analysis of the genome of <italic>S.&#x000a0;coelicolor</italic> detected a putative IPMS (SCO2528) with a sequence identity of 58% on protein level. CysB is a putative major facilitator superfamily (MFS) permease of the DHA2-family. Such transporters have been associated with the extrusion of a variety of chemicals and can confer resistance and self-resistance to antibiotically active compounds (<xref rid="bib24" ref-type="bibr">24</xref>, <xref rid="bib25" ref-type="bibr">25</xref>). We propose that CysB is involved in the export of cystargolides. However, the detected cystargolide production in the respective <italic>&#x00394;cysB</italic> mutant suggests that the function of CysB in cystargolide secretion is supported by the activity of other intrinsic transporter systems. Indeed, analysis of the cell culture supernatant and the mycelium showed that cystargolides are present in both, the medium and the cells. This was observed for the intact gene cluster as well as the <italic>&#x00394;cysB</italic> mutant (<xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S6</xref>). The gene <italic>cysH</italic> encodes a putative LysR-family regulatory protein. These type of proteins are known as transcriptional activators (<xref rid="bib26" ref-type="bibr">26</xref>). LC-MS analysis of the &#x00394;<italic>cysH</italic> mutant culture extracts revealed a drastically reduced cystargolide production (<xref rid="appsec1" ref-type="sec">Table&#x000a0;S6</xref>). This strongly indicates that CysH functions as a positive regulator in regards to the cystargolide biosynthesis. In contrast, the knockouts &#x00394;<italic>cysC</italic>, &#x00394;<italic>cysD</italic>, &#x00394;<italic>cysE</italic>, &#x00394;<italic>cysF</italic> and &#x00394;<italic>cysG</italic> resulted in the complete abolishment of cystargolide formation (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref>). Of those, three genes, <italic>cysC</italic>, <italic>cysD</italic> and <italic>cysF</italic>, code for putative ATP-dependent carboxylic acid-activating enzymes. CysC and CysF show homology to adenylating enzymes. They generate high-energy acyl-AMP phosphoester intermediates to facilitate <italic>e.g.</italic> the formation of amide bonds, coenzyme A and acyl-carrier protein (ACP) thioesters or general transesterification reactions. CysD is predicted as a member of the ATP-grasp family which forms reactive acyl monophosphate intermediates that allow similar biochemistry as the adenylates (<xref rid="bib27" ref-type="bibr">27</xref>, <xref rid="bib28" ref-type="bibr">28</xref>, <xref rid="bib29" ref-type="bibr">29</xref>). We thus conclude that CysC, CysD, and CysF are involved in converting three carboxylic acid groups to form two amides and a cyclic ester in cystargolide biosynthesis. On the other hand, CysG is a putative SAM-dependent methyltransferase whereas CysE is homologous to methylesterases with a predicted alpha/beta-hydrolase topology. Both enzymes have no obvious function in cystargolide biosynthesis, but intriguingly, a similar methyltransferase/methylesterase pair is encoded in the biosynthetic gene cluster of belactosins (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>; <xref rid="appsec1" ref-type="sec">Table&#x000a0;S2</xref>) (<xref rid="bib18" ref-type="bibr">18</xref>, <xref rid="bib30" ref-type="bibr">30</xref>, <xref rid="bib31" ref-type="bibr">31</xref>). This finding led us to speculate that CysE and CysG might be involved in the formation of the characteristic &#x003b2;-lactone warhead. Indeed, the complete loss of cystargolide production in the respective gene deletion mutants appear to support this hypothesis (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref>).</p></sec><sec id="sec1.3"><title>Investigation of the methyltransferase CysG</title><p id="p0035">To further explore the role of CysG in cystargolide biosynthesis we cloned and overexpressed <italic>cysG</italic> in <italic>Escherichia coli</italic> Rosetta DE3 pLysS. Using an <italic>N</italic>-terminal His-tag and Ni-NTA affinity chromatography 10&#x000a0;mg/L pure and soluble recombinant protein was obtained (<xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S7</xref>). Given the absence of a methyl group in the final cystargolide product we wondered if CysG might act on one of the building blocks or their precursors prior to the final compound assembly. We therefore incubated CysG with S-adenosyl methionine (SAM) and 3-isopropylmalate (3-IPM) as a putative acceptor substrate. Strikingly, a single product peak could be detected by LC-MS analysis with <italic>m/z</italic> 191.08 [M&#x000a0;+ H]<sup>+</sup>, matching the expected mono-methylated 3-IPM (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref><italic>A</italic>). This compound was absent in the control assays lacking either CysG or SAM. Since 3-IPM offers three possible targets for methyl-group transfer (2-OH, COOH-1, and COOH-4), the product of the CysG-mediated biotransformation was subjected to structural characterization by NMR spectroscopy (<xref rid="appsec1" ref-type="sec">Figs.&#x000a0;S11&#x02013;S28</xref> and <xref rid="appsec1" ref-type="sec">Tables&#x000a0;S7&#x02013;S9</xref>).<fig id="fig4"><label>Figure&#x000a0;4</label><caption><p><bold>LC-MS analysis of the <italic>in&#x000a0;vitro</italic> enzyme activity of CysG and BelI.</bold><italic>A</italic>, <italic>in&#x000a0;vitro</italic> methylation of 3-isopropyl malate (3-IPM) by the <italic>S</italic>-adenosyl methionine (SAM)-dependent methyltransferase CysG. Total ion chromatograms with highlighted signals for 3-IPM (substrate) and Met 3-IPM (3-IPM-1-methyl ester, product). <italic>B</italic>, <italic>in&#x000a0;vitro</italic> methylation of 3-<italic>sec</italic>-butylmalate (3-sBM) by the <italic>S</italic>-adenosyl methionine (SAM)-dependent methyltransferase BelI. Total ion chromatograms with highlighted signals for 3-sBM (substrate) and methylated 3-sBM (product).</p></caption><graphic xlink:href="gr4"/></fig></p><p id="p0040">A comparison of the 1D NMR spectra of 3-IPM with those of its methylated version revealed that all carbon atoms except C-2 and C-7 experienced slight field shifts in the range of 0.4 to 1&#x000a0;ppm in the <sup>13</sup>C NMR spectrum and that one additional oxygenated methyl group (<italic>&#x003b4;</italic><sub>H/C</sub> 3.60/51.4) was formed (<xref rid="appsec1" ref-type="sec">Tables&#x000a0;S7</xref> and <xref rid="appsec1" ref-type="sec">S8</xref>). In the corresponding <sup>1</sup>H-<sup>13</sup>C-HMBC NMR spectrum, the latter showed long-range correlations either with C-1 or C4, indicating that one of the carboxylic acids was esterified. Due to the biotransformation, C-1 and C-4 shifted and exhibited highly similar <sup>13</sup>C NMR shift values (<italic>&#x003b4;</italic><sub>C</sub> 174.03 and 174.22), which prevented initially an unambiguous assignment. Since the application of a higher magnetic field strength (16.4&#x000a0;T instead of 9.4&#x000a0;T) to increase resolution was only marginally successful, an acetylation strategy was applied. Peracetylation of methylated 3-IPM and subsequent NMR analysis unveiled, that the 2-OH group was acetylated as expected, evidenced by cross peaks H<sub>3</sub>-10/C-9 and H<sub>3</sub>-10/C-2 in the HMBC spectrum. This modification enabled carbon atoms C-1 and C-4 to be sufficiently magnetically non-equivalent and well resolved (<italic>&#x003b4;</italic><sub>C</sub> 169.2 and 171.6, respectively), which allowed the determination of the exact methylation site. Consequently, the observed long-range coupling between H<sub>3</sub>-8 and C-1 (<xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S25</xref>) unequivocally led to the conclusion that the original biotransformation product represented indeed 3-IPM-1-methyl-ester.</p><p id="p0045">Next, we wanted to confirm that the CysG <italic>in&#x000a0;vitro</italic> product is a genuine intermediate in the cystargolide pathway. Therefore, we fed 3-IPM-1-methyl-ester to cultures of the &#x00394;<italic>cysG</italic> mutant strain. LC-MS analysis of the respective extracts revealed that the production of cystargolides was restored only in the supplemented cultures (<xref rid="fig3" ref-type="fig">Figs.&#x000a0;3</xref>, <xref rid="appsec1" ref-type="sec">S9</xref> and <xref rid="appsec1" ref-type="sec">S10</xref>). Chemical complementation was not observed after feeding with non-methylated 3-IPM, demonstrating the importance of the installed 1-methyl group for the subsequent biosynthetic steps in cystargolide biosynthesis.</p><p id="p0050">Our unexpected findings on the role of CysG in cystargolide formation prompted us to examine if the homologous enzyme BelI has a similar function in belactosin biosynthesis. Therefore, we cloned and overexpressed <italic>belI</italic> in <italic>E.&#x000a0;coli</italic> BL21(DE3) to obtain pure and soluble recombinant protein with an <italic>N</italic>-terminal His<sub>6</sub>-SUMO-tag (<xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S8</xref>). Because the predicted substrate of BelI 3-<italic>sec</italic> butylmalate, was not commercially available we accessed this compound by chemical synthesis using diethyl malate and 2-iodobutane as starting materials (<xref rid="bib32" ref-type="bibr">32</xref>, <xref rid="bib33" ref-type="bibr">33</xref>). In the next step, BelI was incubated with SAM and authentic 3-<italic>sec</italic> butylmalate to provide a single product peak in LC-MS chromatograms (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref><italic>B</italic>). The respective molecular ion had a mass-to-charge ratio of <italic>m/z</italic> 202.69 [M&#x000a0;+ H]<sup>+</sup>, matching the expected mono-methylated 3-<italic>sec</italic> butylmalate. A similar compound was not identified in the control assays lacking either BelI or SAM. These results clearly showed that the biosynthesis of the &#x003b2;-lactone warhead moiety of cystargolides and belactosins proceeds <italic>via</italic> a cryptic methylated intermediate prior to cyclization.</p></sec></sec><sec id="sec2"><title>Discussion</title><p id="p0055">In this study we identified and isolated a cystargolide gene cluster from <italic>S.&#x000a0;durhamensis</italic> NRRL-B3309. The cluster contains eight genes, which are homologs of the original <italic>cys</italic> BGC from <italic>K.&#x000a0;cystarginea</italic> NRRL B16505. <italic>Via</italic> heterologous expression, we could unambiguously connect this BGC to the biosynthesis of cystargolides, confirming that it contains all genes necessary for the production of cystargolide A and B. Furthermore, we were able to demonstrate that the genes <italic>cys</italic>C-<italic>cys</italic>G are essential for this process. The putative methyltransferase CysG readily methylated 3-IPM <italic>in&#x000a0;vitro</italic>, suggesting that it catalyzes the same reaction in the cystargolide biosynthetic pathway and plays a crucial role in the formation of the &#x003b2;-lactone warhead. The methylation occurs at the C-1 carboxylic acid group of 3-IPM as revealed by NMR spectroscopy, proving that this modification is not involved in the lactonization. Thus we propose that CysG might act as a diverter, committing the primary metabolite 3-IPM to cystargolide biosynthesis and/or masking the 1-carboxylic acid group for the following biotransformations. These findings were supported by the functional characterization of the CysG homolog BelI. BelI catalyzed the methylation of 3-<italic>sec</italic> butylmalate in a SAM-dependent manner. Intriguingly, CysG and CysE as well as BelI and BelR exhibit conserved protein domains that are found in the methyltransferase/methylesterase pair BioC/BioH of the biotin synthesis pathway in proteobacteria (<xref rid="appsec1" ref-type="sec">Figs.&#x000a0;S1</xref> and <xref rid="appsec1" ref-type="sec">S2</xref>) (<xref rid="bib34" ref-type="bibr">34</xref>). BioC catalyzes a SAM-dependent methyl esterification of malonyl-ACP allowing its recognition as a starter unit by house-keeping charge-sensitive fatty acid synthetases. After two reiterations of the fatty acid elongation cycle, the generated pimeloyl-ACP methyl ester is hydrolyzed to pimeloyl-ACP and methanol by BioH. Pimeloyl-ACP is then further converted to biotin. One might speculate about a similar role for CysG and CysE in cystargolide biosynthesis. In this reaction trajectory the 3-IPM-1-methyl-ester product of CysG would undergo lactonization to afford a &#x003b2;-lactone methyl ester building block. Prior to amidation, the 1-carboxyl group is presumably liberated by CysE. Investigations to explore this hypothesis and open questions about the formation of the &#x003b2;-lactone warhead of cystargolides and belactosins will be addressed in future studies.</p></sec><sec id="sec3"><title>Experimental procedures</title><sec id="sec3.1"><title>General experiments</title><p id="p0060">Chemicals, micro-, and molecular biological agents were acquired from standard commercial sources. <italic>S.&#x000a0;coelicolor</italic> M512 and its derivatives were grown and maintained on MS agar (2% (w/v) soy flour purchased from Sobo Naturkost, 2% (w/v) mannitol purchased from Roth, 2% (w/v) agar purchased from Becton Dickinson) (<xref rid="bib35" ref-type="bibr">35</xref>). Liquid cultures were either cultivated in Tryptic Soy Broth (TSB) medium (purchased from Becton Dickinson) or in SM1 Medium (10% (w/v) soy flour, 18% glucose, 1% Na<sub>2</sub>SO<sub>4</sub> and 0.2% CaCO<sub>3</sub>). <italic>E.&#x000a0;coli</italic> strains were grown in lysogeny broth (LB) medium supplemented with appropriate antibiotics. DNA isolation and manipulations were carried out according to standard methods for <italic>E.&#x000a0;coli</italic> (<xref rid="bib36" ref-type="bibr">36</xref>) and <italic>Streptomyces</italic> (<xref rid="bib35" ref-type="bibr">35</xref>).</p></sec><sec id="sec3.2"><title>Human proteasome inhibition assay</title><p id="p0065">The 20S human proteasome activity was analyzed using the chymotryptic model substrate LLVY-AMC (Bachem). LLVY-AMC was prediluted in assay buffer to a concentration of 50&#x000a0;&#x003bc;M (20&#x000a0;mM HEPES, pH 7.8, 0.5&#x000a0;mM EDTA/0.035% SDS), and varying dilutions of culture extracts (1:300 and 1:600) were added. The reaction was started by the addition of the human proteasome (Enzo Life Sciences: BML-PW8720-0050) to a final concentration of 0.4&#x000a0;&#x003bc;g/ml at a reaction volume of 100&#x000a0;&#x003bc;l to monitor substrate conversion. The fluorescence was followed over time in a spectrofluorometer (Tecan Spark, Tecan Trading AG) at &#x003bb;ex&#x000a0;= 380&#x000a0;nm and &#x003bb;em&#x000a0;= 460&#x000a0;nm. All measurements were performed in triplicates and two independent experiments were performed.</p></sec><sec id="sec3.3"><title>TAR-cloning</title><p id="p0070">The vector pCAP03-acc(3)IV was used to isolate the <italic>cys</italic> BGC from <italic>S.&#x000a0;durhamensis</italic> NRRL-B3309 creating cysDM02 following published transformation-assisted recombination protocols (<xref rid="bib21" ref-type="bibr">21</xref>). Therefore, homologous hooks of 299&#x000a0;bp (<xref rid="appsec1" ref-type="sec">Table&#x000a0;S3</xref>) were integrated in pCAP03-acc(3)IV by Gibson assembly. The vector was linearized by restriction digest with XhoI and NdeI. For the preparation of spheroplasts <italic>S.&#x000a0;cerevisiae</italic> VL6-48N was cultured in 50&#x000a0;ml YPD medium (20&#x000a0;g/L peptone, 20&#x000a0;g/L glucose, 10&#x000a0;g/L yeast extract) with 1% (w/v) adenine 2% (w/v) glucose until an OD<sub>660</sub> of 3.0 was reached. The cells were harvested at 4 &#x000b0;C and 2000<italic>g</italic> for 5&#x000a0;min and resuspended in 30&#x000a0;ml&#x000a0;H<sub>2</sub>O. After another centrifugation step at 3000<italic>g</italic> the pellet was resuspended in 20&#x000a0;ml ice-cold 1&#x000a0;M D-sorbit. The cells were incubated on ice for 30&#x000a0;min, centrifuged at 4 &#x000b0;C and 3000<italic>g</italic> for 5&#x000a0;min and resuspended in 20&#x000a0;ml SPE solution. 125&#x000a0;&#x003bc;l zymolyase and 40&#x000a0;&#x003bc;l &#x003b2;-mercaptoethanol were added and the suspension was incubated at 30 &#x000b0;C and 200&#x000a0;rpm until spheroplast generation was complete. Progress was monitored by measuring the OD<sub>660</sub> of 100&#x000a0;&#x003bc;l&#x000a0;cells diluted with 900&#x000a0;&#x003bc;l 1M D-sorbit solution. The measurements were compared to the OD<sub>660</sub> of 100&#x000a0;&#x003bc;l&#x000a0;cells diluted in a 2% (v/v) sodium dodecyl sulfate (SDS) solution.</p></sec><sec id="sec3.4"><title>Construction of deletion mutants</title><p id="p0075">Single gene knockouts in the <italic>cys</italic> BGC were generated by PCR-targeting using &#x003bb;-RED recombineering (<xref rid="bib23" ref-type="bibr">23</xref>). Therefore, an apramycin resistance cassette was amplified and extended from pIJ773 by PCR (<xref rid="appsec1" ref-type="sec">Table&#x000a0;S5</xref> and <xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S4</xref>). The PCR product was transferred into <italic>E.&#x000a0;coli</italic> BW25113/pKD46 containing fosmid cysDM02 (<xref rid="bib37" ref-type="bibr">37</xref>). After confirmation with restriction analysis, the resistance cassette was removed in <italic>E.&#x000a0;coli</italic> BT340 to avoid polar effects taking advantage of the flanking FLP/FRT recognition site (<xref rid="bib38" ref-type="bibr">38</xref>). The resulting construct was transferred into <italic>E.&#x000a0;coli</italic> ET12567 (<xref rid="bib39" ref-type="bibr">39</xref>) and introduced into <italic>S.&#x000a0;coelicolor</italic> M512, by triparental mating with the help of <italic>E.&#x000a0;coli</italic> pUB307 (<xref rid="bib40" ref-type="bibr">40</xref>). Three independent kanamycin-resistant clones were selected for each experiment and designated <italic>S.&#x000a0;coelicolor</italic> M512/cysDM02 1&#x02013;3, <italic>S.&#x000a0;coelicolor</italic> M512/cysDM02A (&#x00394;<italic>cysA</italic>) 1&#x02013;3, <italic>S.&#x000a0;coelicolor</italic> M512/cysDM02B (&#x00394;<italic>cysB</italic>) 1&#x02013;3, <italic>S.&#x000a0;coelicolor</italic> M512/cysDM02C (&#x00394;<italic>cysC</italic>) 1&#x02013;3, <italic>S.&#x000a0;coelicolor</italic> M512/cysDM02D (&#x00394;<italic>cysD</italic>) 1&#x02013;3, <italic>S.&#x000a0;coelicolor</italic> M512/cysDM02E (&#x00394;<italic>cysE</italic>) 1&#x02013;3, <italic>S.&#x000a0;coelicolor</italic> M512/cysDM02F (&#x00394;<italic>cysF</italic>) 1&#x02013;3, <italic>S.&#x000a0;coelicolor</italic> M512/cysDM02G (&#x00394;<italic>cysG</italic>) 1&#x02013;3, <italic>S.&#x000a0;coelicolor</italic> M512/cysDM02H (&#x00394;<italic>cysH</italic>) 1&#x02013;3. Successful integration of the clusters into the <italic>S.&#x000a0;coelicolor</italic> M512 genome was confirmed by PCR (<xref rid="appsec1" ref-type="sec">Table&#x000a0;S4</xref>).</p></sec><sec id="sec3.5"><title>Heterologous production of cystargolides</title><p id="p0080">For the heterologous production of cystargolides, 50&#x000a0;ml of TSB medium were inoculated with 10&#x000a0;&#x003bc;l spore suspension of <italic>S.&#x000a0;coelicolor</italic> M512 derivatives and cultivated for 48&#x000a0;h at 30 &#x000b0;C and 200&#x000a0;rpm with appropriate antibiotics. 1&#x000a0;ml of pre-culture was transferred to 50&#x000a0;ml SM1 (<xref rid="bib41" ref-type="bibr">41</xref>). Cells were cultivated for 7&#x000a0;days at 30 &#x000b0;C, 200&#x000a0;rpm and extracted as described below.</p></sec><sec id="sec3.6"><title>Extraction and analysis of cystargolides</title><p id="p0085">For the extraction of cystargolide, 750&#x000a0;&#x003bc;l of cell culture was thoroughly mixed with the same volume of ethyl acetate (EtOAc), followed by separation of the phases by centrifugation at 1500<italic>g</italic> for 5&#x000a0;min. The organic phase was collected and evaporated to dryness in a vacuum concentrator. The extracts were dissolved in acetonitrile (MeCN) and subjected to LC&#x02013;MS analysis. The routine analysis of culture extracts by LC&#x02013;MS and MS/MS was performed on a LC/MSD Ultra Trap System XCT6330 (Agilent 1200 series; Agilent Technologies). Samples (2.5&#x000a0;&#x003bc;l) were injected onto a reverse phase column (Nucleosil 100-3 C18, particle size 3&#x000a0;&#x003bc;m, pore size 100&#x000a0;&#x000c5;, 100&#x000a0;&#x000d7; 2&#x000a0;mm fitted with a precolumn 10&#x000a0;&#x000d7; 2&#x000a0;mm) at a flow rate of 0.4&#x000a0;ml/min and a linear gradient of solvent B from t<sub>0</sub>&#x000a0;= 0% to t<sub>15</sub>&#x000a0;= 100% (solvent A: water with 0.1% formic acid, solvent B: MeCN with 0.06% formic acid) for cystargolide A and B detection. Ionization and mass analysis was performed by ESI (positive and negative ionization) in Ultra Scan mode with a capillary voltage of 3.5&#x000a0;kV and a drying gas temperature of 350 &#x000b0;C.</p></sec><sec id="sec3.6.1"><title><italic>NMR an</italic><italic>al</italic><italic>ysis</italic></title><p id="p0090">NMR solvents were obtained from Sigma-Aldrich. 1D and 2D NMR spectra were acquired either with a Bruker Avance III HD 400&#x000a0;MHz NMR spectrometer, using a 5&#x000a0;mm SMART probe head, or with a Bruker Avance III HDX spectrometer 700&#x000a0;MHz NMR spectrometer (Bruker BioSpin GmbH, Rheinstetten, Germany), equipped with a 5&#x000a0;mm Prodigy TCI CryoProbe head. NMR spectra were measured in <italic>d</italic><sub>6</sub>-DMSO at 293&#x000a0;K and were referenced to residual solvent signals (<italic>d</italic><sub>6</sub>-DMSO: <italic>&#x003b4;</italic><sub>H</sub>&#x000a0;= 2.50 and <italic>&#x003b4;</italic><sub>C</sub>&#x000a0;= 39.5&#x000a0;ppm).</p></sec><sec id="sec3.7"><title>Cloning, expression, and purification of CysG</title><p id="p0095">The gene <italic>cysG</italic> was amplified from the genomic DNA of <italic>K.&#x000a0;cystarginea</italic>. The PCR product was cloned into pET15b containing an <italic>N</italic>-terminal 6xHis-tag. The resulting plasmid pET15b-<italic>cysG</italic> was verified by sequencing (Eurofins genomics) and transferred into <italic>E.&#x000a0;coli</italic> Rosetta (DE3) pLysS by electroporation. A single colony was inoculated in 10&#x000a0;ml LB medium containing 50&#x000a0;&#x003bc;g/ml ampicillin and cultivated at 220&#x000a0;rpm and 37 &#x000b0;C until an OD<sub>600</sub> of approximately 0.6 was reached. This preculture was used to inoculate 1&#x000a0;L LB medium containing 50&#x000a0;&#x003bc;g/ml ampicillin, which was grown to an OD<sub>600</sub> of approximately 0.6. The expression of His<sub>6</sub>-CysG was induced by the addition of Isopropyl &#x003b2;&#x02013;d-1-thiogalactopyranoside (IPTG) to a final concentration of 0.5&#x000a0;mM and the culture was cultivated overnight at 250&#x000a0;rpm and 20 &#x000b0;C. Cells were harvested by centrifugation (4000<italic>g</italic>, 5&#x000a0;min, 4 &#x000b0;C) and resuspended in 25&#x000a0;ml lysis buffer (50&#x000a0;mM Tris-HCl, 500&#x000a0;mM NaCl, 10%(v/v) glycerol, 10&#x000a0;mM &#x003b2;-mercaptoethanol, 1% (v/v) TWEEN 20, 20&#x000a0;mM imidazole, 0.5&#x000a0;mg/ml lysozyme, 0.5&#x000a0;mM PMSF). Cell lysis was performed by sonication for 10&#x000a0;min (ultrasonic disintegrator set to amp 30%, pulse 5s/5s rest). The suspension was centrifuged (18,000&#x000a0;rpm, 45&#x000a0;min, 4 &#x000b0;C) and the soluble fraction was filtered (0.2&#x000a0;&#x003bc;M pore size). IMAC purification was performed by fast protein liquid chromatography (&#x000c4;KTA Start) with a 5&#x000a0;ml HisTrap Ni-NTA column (GE Healthcare). The column was washed with 8 column volumes (CV) of binding buffer (50&#x000a0;mM Tris-HCl, 500&#x000a0;mM NaCl, 10% (v/v) glycerol, 10&#x000a0;mM &#x003b2;-mercaptoethanol, 20&#x000a0;mM imidazole) and eluted with 9 CVs of elution buffer (50&#x000a0;mM Tris-HCl, 500&#x000a0;mM NaCl, 10% (v/v) glycerol, 10&#x000a0;mM &#x003b2;-mercaptoethanol, 250&#x000a0;mM imidazole) using a gradient increasing from 0% to 100%. Protein purity was determined by SDS-PAGE. Buffer exchange and concentration of proteins were performed with Amicon Ultra-15 centrifugal units.</p></sec><sec id="sec3.8"><title>Cloning, expression, and purification of BelI</title><p id="p0100">The synthetic gene fragment optimized for <italic>E.&#x000a0;coli</italic> codon usage of BelI (GenBank <ext-link ext-link-type="NCBI:protein" xlink:href="ARO49577.1" id="intref0010">ARO49577.1</ext-link>) was cloned into a pETDuet expression vector modified to encode an N-terminal His<sub>6</sub>-SUMO tag using NEBuilder HiFi DNA Assembly following the manufacturer&#x02019;s instructions. Correct insertion was verified by Sanger sequencing (Eurofins genomics). <italic>E.&#x000a0;coli</italic> BL21(DE3) cells were transformed by electroporation and grown in glass shake flasks containing 2&#x000a0;L lysogenic broth with 100&#x000a0;&#x003bc;g/ml ampicillin at 37&#x02009; &#x000b0;C. After reaching an optical density measured at a wavelength of 600&#x000a0;nm (OD600) of 0.6, flasks were stored at 4 &#x02009;&#x000b0;C for 30&#x000a0;min before adding 0.5&#x000a0;mM isopropyl-&#x003b2;-<italic>D</italic>-1-thiogalactopyranoside (final concentration) to induce protein expression, which occurred overnight at 20&#x02009; &#x000b0;C. Cells were harvested by centrifugation, washed with 0.9% (w/v) NaCl and cell pellets stored at&#x000a0;&#x02212;20&#x02009; &#x000b0;C until further use. <italic>E.&#x000a0;coli</italic> cell pellets of 10&#x000a0;g were dissolved in 50&#x000a0;ml buffer A (100&#x000a0;mM Tris/HCl pH 7.5, 200&#x000a0;mM NaCl, 20&#x000a0;mM imidazole, 2&#x000a0;mM 2-mercaptoethanol) and lysed by sonication (Branson Digital Sonifier 250). After centrifugation (40,000<italic>g</italic>, 4 &#x02009;&#x000b0;C, 30&#x000a0;min), the supernatant was applied to a 5&#x000a0;ml HisTrap HP column at a flow rate of 5&#x000a0;ml/min with an &#x000c4;KTA Pure system (Cytiva), previously equilibrated with buffer A. After washing with buffer A, the protein of interest was eluted by applying a 50&#x000a0;ml linear gradient from buffer A to buffer B (100&#x000a0;mM Tris/HCl pH 7.5, 200&#x000a0;mM NaCl, 500&#x000a0;mM imidazole, 2&#x000a0;mM 2-mercaptoethanol). Fractions containing protein were pooled and supplemented with SUMO-protease to remove the His<sub>6</sub>-SUMO-tag and dialyzed overnight at 4 &#x000b0;C against buffer C (20&#x000a0;mM Tris/HCl pH 7.5, 200&#x000a0;mM NaCl, 2&#x000a0;mM 2-mercaptoethanol). HisTrap affinity chromatography was repeated and the flow-through was concentrated to 4&#x000a0;ml using Amicon Ultra-15 centrifugal filters. Centrifugation (16,000<italic>g</italic>, 4 &#x02009;&#x000b0;C, 15&#x000a0;min) removed residual protein aggregates, and the supernatant was used for size exclusion chromatography with a HiLoad Superose 6 pg 16/600 column in buffer D (20&#x000a0;mM Tris/HCl pH 7.5, 200&#x000a0;mM NaCl, 2&#x000a0;mM dithiothreitol) at 1.0&#x000a0;ml/min. High purity peak fractions were pooled and concentrated to at least 10&#x000a0;mg/ml.</p></sec><sec id="sec3.9"><title>Chemical synthesis</title><p id="p0105">Standard laboratory glassware and equipment were used to carry out all experiments. All chemicals and solvents (technical, dry, deuterated, HPLC grade, and MS grade) were purchased from Sigma Aldrich, Carl Roth or Acros and used without further purification. Removal of volatiles was implemented on a BUCHI Rotavapor R-215 with a Thermo Haake K10/DC10 cooling system. The ambient temperature was between 22 to 23 &#x000b0;C. Purifications of chemical products were performed on a BUCHI Pure C-815 Flash Chromatography System using appropriate FlashPure EcoFlex Silica cartridges and solvents. Analytical thin-layer chromatography was performed on aluminium-coated TLC silica gel plates (silica gel 60, F254, Merck). For visualization, ultra-violet irradiation (&#x003bb;&#x000a0;=&#x000a0;254, 366&#x000a0;nm) and/or staining using potassium permanganate solution (3.0&#x000a0;g KMnO<sub>4</sub>, 20.0&#x000a0;g&#x000a0;K<sub>2</sub>CO<sub>3</sub>, and 5&#x000a0;ml 5% NaOH in 300&#x000a0;ml ddH2O) with subsequent heat treatment were used.</p><p id="p0110">MS-measurements were recorded on an Agilent Infinity II 1290 LCMS system equipped with a Single Quadrupol MS (6100 series, AJS ion source) and a C18-column (Poroshell 120 EC-C18, 1.9&#x000a0;&#x003bc;m, 2.1&#x000a0;&#x000d7; 100&#x000a0;mm) using a 5 to 95% H<sub>2</sub>O-acetonitrile (ACN) gradient over 10&#x000a0;min with a flow rate of 0.4&#x000a0;ml/min. Solvents were supplemented with 0.1% formic acid. The applied scan range was m/z 100 to 2000 in positive and negative mode.</p><p id="p0115">Nuclear magnetic resonance spectroscopy experiments (<sup>1</sup>H,&#x000a0;<sup>13</sup>C) were conducted using a <italic>Bruker</italic> AVHD-400 instrument at 303&#x000a0;K operating at 400&#x000a0;MHz and 101&#x000a0;MHz, respectively. Chemical shifts are reported in part per million (ppm) and referred to the solvent signal. The coupling constants are given in Hz and the multiplicities of the <sup>1</sup>H-NMR are defined as s-singlet, d-doublet, dd-doublet of doublets, t-triplet, m-multiplet.</p></sec><sec id="sec3.10"><title>3-<italic>sec</italic>-butylmalate diethylester</title><p id="p0120">Under an atmosphere of nitrogen, lithium bis(trimethylsilyl)amide solution (1&#x000a0;M in THF, 23.13&#x000a0;ml, 23.1&#x000a0;mmol, 2.2 eq.) was cooled to&#x000a0;&#x02212;78 &#x000b0;C. Diethyl malate (2.0&#x000a0;g, 10.5&#x000a0;mmol, 1.0 eq.), dissolved in 10&#x000a0;ml THF, was added dropwise over 30&#x000a0;min and the reaction mixture was stirred at&#x000a0;&#x02212;78 &#x000b0;C for 1&#x000a0;h. The reaction was stirred and allowed to warm to 20 &#x000b0;C for an additional hour. Afterwards, the reaction mixture was cooled to&#x000a0;&#x02212;78 &#x000b0;C and 2-iodobutane (3.27&#x000a0;ml, 28.4&#x000a0;mmol, 2.7 eq.) was added over 10&#x000a0;min and stirred for 1&#x000a0;h at&#x000a0;&#x02212;78 &#x000b0;C. The reaction mixture was stirred overnight while allowing to reach ambient temperature. The reaction was quenched with 200&#x000a0;ml saturated ammonium chloride solution and extracted with ethyl acetate (3&#x000a0;&#x000d7; 100&#x000a0;ml). The combined organic phases were washed with brine (2&#x000a0;&#x000d7;&#x000a0;30&#x000a0;ml), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude product was purified with a BUCHI Pure C-815 Flash Chromatography System using a FlashPure EcoFlex Silica 12g cartridge using ethyl acetate and hexane (1:2) as solvents. 3-<italic>sec</italic>-butylmalate diethylester (693&#x000a0;mg, 2.8&#x000a0;mmol, 27%) was obtained as a pale-yellow oil.</p><p id="p0125"><sup><bold>1</bold></sup><bold>H NMR</bold> (400&#x000a0;MHz, CDCl<sub>3</sub>) &#x003b4; [ppm]&#x000a0;= 4.36 (dd, <italic>J</italic>&#x000a0;= 9.4, 3.6&#x000a0;Hz, 1H), 4.20 to 4.17 (m, 4H), 2.85 to 2.75 (m, 1H), 2.70 to 2.65 (m, 1H), 1.29 to 1.26 (m, 8H), 0.97 (d, <italic>J</italic>&#x000a0;= 6.8&#x000a0;Hz, 3H), 0.92 (t, <italic>J</italic>&#x000a0;= 7.4&#x000a0;Hz, 3H).</p><p id="p0130"><sup><bold>13</bold></sup><bold>C NMR</bold> (101&#x000a0;MHz, CDCl3) &#x003b4; [ppm]&#x000a0;= 174.04, 172.90, 68.63, 53.67, 50.81, 47.81, 33.90, 26.85, 17.32, 14.65, 14.56, 11.27.</p><p id="p0135"><bold>MS:</bold> (+ESI): calc. for C<sub>12</sub>H<sub>22</sub>O<sub>5</sub>Na [M+Na]<sup>+</sup>: 269.15; found 269.1.</p></sec><sec id="sec3.11"><title>3-<italic>sec</italic>-butylmalate</title><p id="p0140">Under an atmosphere of nitrogen, 3-<italic>sec</italic>-butylmalate diethylester (200&#x000a0;mg, 0.8&#x000a0;mmol, 1.0 eq.) was dissolved in 2.7&#x000a0;ml methanol at 0 &#x000b0;C. Potassium hydroxide (200&#x000a0;mg, 3.6&#x000a0;mmol, 4.4 eq.) was added in one portion and stirred at 0 &#x000b0;C for 2&#x000a0;h. Volatiles were removed under reduced pressure and 3-<italic>sec</italic>-butylmalate (134&#x000a0;mg, 0.7&#x000a0;mmol, 87%) was obtained as a pale-yellow solid.</p><p id="p0145"><sup><bold>1</bold></sup><bold>H NMR</bold> (400&#x000a0;MHz, MeOD) &#x003b4; [ppm]&#x000a0;= 4.07 (d, <italic>J</italic>&#x000a0;= 2.8&#x000a0;Hz, 1H), 2.69 to 2.54 (m, 1H), 2.43 to 2.38 (m, 1H), 1.29 to 1.16 (m, 2H), 1.00 (d, <italic>J</italic>&#x000a0;= 6.8&#x000a0;Hz, 3H), 0.93 (t, <italic>J</italic>&#x000a0;= 7.5&#x000a0;Hz, 3H).</p><p id="p0150"><sup><bold>13</bold></sup><bold>C NMR</bold> (101&#x000a0;MHz, MeOD) &#x003b4; [ppm]&#x000a0;= 181.6, 180.4, 73.2, 58.1, 35.0, 27.4, 18.0, 11.4.</p><p id="p0155"><bold>MS</bold> (&#x02212;ESI): calc. for C<sub>8</sub>H<sub>13</sub>O<sub>5</sub> [M&#x02212;H]<sup>&#x02212;</sup>: 189.08; found 189.1.</p></sec><sec id="sec3.12"><title>CysG and BelI enzyme assay conditions</title><p id="p0160">A standard CysG enzyme assay contained 1&#x000a0;mM 3-IPM, 1&#x000a0;mM SAM, and 5&#x000a0;&#x003bc;M His<sub>6</sub>-CysG. The BelI enzyme assay contained 1&#x000a0;mM 3-<italic>sec</italic>-butylmalate, 1&#x000a0;mM SAM and 5&#x000a0;&#x003bc;M BelI. Both assays were conducted in a total of 50&#x000a0;&#x003bc;l reaction volume in the presence of enzyme assay buffer (50&#x000a0;mM Tris-HCl, 20&#x000a0;mM MgCl<sub>2</sub>, 20&#x000a0;mM KCl, 10% (v/v) glycerol). The assay was started by the addition of 3-IPM or 3-<italic>sec</italic>-butylmalate respectively and the reaction was run for 3&#x000a0;h at 30 &#x000b0;C. The reaction was stored at&#x000a0;&#x02212;20 &#x000b0;C until subjected to LC-MS analysis or purification. Negative controls did not contain 3-IPM, SAM, or the enzyme.</p></sec><sec id="sec3.13"><title>Acetylation reaction</title><p id="p0165">3-IPM-1-methyl-ester was incubated with 1&#x000a0;ml of pyridine (water-free) and 1&#x000a0;ml of acetic anhydride overnight under light exclusion. The acetylated product was precipitated with 20&#x000a0;ml of ice-cold water. Subsequently, the substance was extracted three times with 20&#x000a0;ml of chloroform. The organic phase was washed twice with distilled water and dried with Na<sub>2</sub>SO<sub>4</sub>. After the removal of the solvents using a laboratory freeze-dryer (&#x02212;105 &#x000b0;C), the reaction product was analyzed by analytical HPLC and subjected to NMR measurements.</p></sec></sec><sec sec-type="data-availability" id="sec4"><title>Data availability</title><p id="p0170">All data presented are contained within the article.</p></sec><sec sec-type="supplementary-material" id="sec5"><title>Supporting information</title><p id="p0175">This article contains <xref rid="appsec1" ref-type="sec">supporting information</xref>.</p></sec><sec sec-type="COI-statement"><title>Conflict of interest</title><p id="p0180">The authors declare no conflicts of interest with the contents of the article.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Groll</surname><given-names>M.</given-names></name><name><surname>Ditzel</surname><given-names>L.</given-names></name><name><surname>L&#x000f6;we</surname><given-names>J.</given-names></name><name><surname>Stock</surname><given-names>D.</given-names></name><name><surname>Bochtler</surname><given-names>M.</given-names></name><name><surname>Bartunik</surname><given-names>H.D.</given-names></name><etal/></person-group><article-title>Structure of 20S proteasome from yeast at 2.4 &#x000c5; resolution</article-title><source>Nature</source><volume>386</volume><year>1997</year><fpage>463</fpage><lpage>471</lpage><pub-id pub-id-type="pmid">9087403</pub-id>
</element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Ciechanover</surname><given-names>A.</given-names></name></person-group><article-title>Proteolysis: from the lysosome to ubiquitin and the proteasome</article-title><source>Nat. Rev. Mol. Cell Biol.</source><volume>6</volume><year>2005</year><fpage>79</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">15688069</pub-id>
</element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Clurman</surname><given-names>B.E.</given-names></name><name><surname>Sheaff</surname><given-names>R.J.</given-names></name><name><surname>Thress</surname><given-names>K.</given-names></name><name><surname>Groudine</surname><given-names>M.</given-names></name><name><surname>Roberts</surname><given-names>J.M.</given-names></name></person-group><article-title>Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation</article-title><source>Genes. Dev.</source><volume>10</volume><year>1996</year><fpage>1979</fpage><lpage>1990</lpage><pub-id pub-id-type="pmid">8769642</pub-id>
</element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Orlowski</surname><given-names>R.Z.</given-names></name></person-group><article-title>The role of the ubiquitin-proteasome pathway in apoptosis</article-title><source>Cell Death Differ.</source><volume>6</volume><year>1999</year><fpage>303</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">10381632</pub-id>
</element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Rock</surname><given-names>K.L.</given-names></name><name><surname>Goldberg</surname><given-names>A.L.</given-names></name></person-group><article-title>Degradation of cell proteins and the generation of MHC class I-presented peptides</article-title><source>Annu. Rev. Immunol.</source><volume>17</volume><year>1999</year><fpage>739</fpage><lpage>779</lpage><pub-id pub-id-type="pmid">10358773</pub-id>
</element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>J.N.</given-names></name><name><surname>Hanni</surname><given-names>K.B.</given-names></name><name><surname>Markesbery</surname><given-names>W.R.</given-names></name></person-group><article-title>Impaired proteasome function in Alzheimer's disease</article-title><source>J.&#x000a0;Neurochem.</source><volume>75</volume><year>2000</year><fpage>436</fpage><lpage>439</lpage><pub-id pub-id-type="pmid">10854289</pub-id>
</element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Ortega</surname><given-names>Z.</given-names></name><name><surname>Lucas</surname><given-names>J.J.</given-names></name></person-group><article-title>Ubiquitin&#x02013;proteasome system involvement in Huntington&#x02019;s disease</article-title><source>Front. Mol. Neurosci.</source><volume>7</volume><year>2014</year><fpage>77</fpage><pub-id pub-id-type="pmid">25324717</pub-id>
</element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Pagan</surname><given-names>J.</given-names></name><name><surname>Seto</surname><given-names>T.</given-names></name><name><surname>Pagano</surname><given-names>M.</given-names></name><name><surname>Cittadini</surname><given-names>A.</given-names></name></person-group><article-title>Role of the ubiquitin proteasome system in the heart</article-title><source>Circ. Res.</source><volume>112</volume><year>2013</year><fpage>1046</fpage><lpage>1058</lpage><pub-id pub-id-type="pmid">23538275</pub-id>
</element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Almond</surname><given-names>J.</given-names></name><name><surname>Cohen</surname><given-names>G.</given-names></name></person-group><article-title>The proteasome: a novel target for cancer chemotherapy</article-title><source>Leukemia</source><volume>16</volume><year>2002</year><fpage>433</fpage><lpage>443</lpage><pub-id pub-id-type="pmid">11960320</pub-id>
</element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Crawford</surname><given-names>L.J.</given-names></name><name><surname>Walker</surname><given-names>B.</given-names></name><name><surname>Irvine</surname><given-names>A.E.</given-names></name></person-group><article-title>Proteasome inhibitors in cancer therapy</article-title><source>J.&#x000a0;Cell Commun. Signal.</source><volume>5</volume><year>2011</year><fpage>101</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">21484190</pub-id>
</element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>K.A.</given-names></name><name><surname>Berru&#x000e9;</surname><given-names>F.</given-names></name><name><surname>Arens</surname><given-names>J.C.</given-names></name><name><surname>Carr</surname><given-names>G.</given-names></name><name><surname>Kerr</surname><given-names>R.G.</given-names></name></person-group><article-title>Cystargolides, 20S proteasome inhibitors isolated from Kitasatospora cystarginea</article-title><source>J.&#x000a0;Nat. Prod.</source><volume>78</volume><year>2015</year><fpage>822</fpage><lpage>826</lpage><pub-id pub-id-type="pmid">25769015</pub-id>
</element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Niroula</surname><given-names>D.</given-names></name><name><surname>Hallada</surname><given-names>L.P.</given-names></name><name><surname>Le Chapelain</surname><given-names>C.</given-names></name><name><surname>Ganegamage</surname><given-names>S.K.</given-names></name><name><surname>Dotson</surname><given-names>D.</given-names></name><name><surname>Rogelj</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Design, synthesis, and evaluation of cystargolide-based beta-lactones as potent proteasome inhibitors</article-title><source>Eur. J. Med. Chem.</source><volume>157</volume><year>2018</year><fpage>962</fpage><lpage>977</lpage><pub-id pub-id-type="pmid">30165344</pub-id>
</element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="optHX6pmlrmA2"><person-group person-group-type="author"><name><surname>Illigmann</surname><given-names>A.</given-names></name><name><surname>Vielberg</surname><given-names>M.T.</given-names></name><name><surname>Lakemeyer</surname><given-names>M.</given-names></name><name><surname>Wolf</surname><given-names>F.</given-names></name><name><surname>Dema</surname><given-names>T.</given-names></name><name><surname>Stange</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Structure of Staphylococcus aureus ClpP bound to the covalent active-site inhibitor cystargolide A</article-title><source>Angew. Chem. Int. Ed.</source><year>2023</year><object-id pub-id-type="publisher-id">e202314028</object-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Asai</surname><given-names>A.</given-names></name><name><surname>Hasegawa</surname><given-names>A.</given-names></name><name><surname>Ochiai</surname><given-names>K.</given-names></name><name><surname>Yamashita</surname><given-names>Y.</given-names></name><name><surname>Mizukami</surname><given-names>T.</given-names></name></person-group><article-title>Belactosin A, a novel antituor antibiotic acting on cyclin/CDK mediated cell cycle regulation, produced by Streptomyces sp</article-title><source>J.&#x000a0;Antibiot.</source><volume>53</volume><year>2000</year><fpage>81</fpage><lpage>83</lpage></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Groll</surname><given-names>M.</given-names></name><name><surname>Larionov</surname><given-names>O.V.</given-names></name><name><surname>Huber</surname><given-names>R.</given-names></name><name><surname>de Meijere</surname><given-names>A.</given-names></name></person-group><article-title>Inhibitor-binding mode of homobelactosin C to proteasomes: new insights into class I MHC ligand generation</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>103</volume><year>2006</year><fpage>4576</fpage><lpage>4579</lpage><pub-id pub-id-type="pmid">16537370</pub-id>
</element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>S.L.</given-names></name><name><surname>Christenson</surname><given-names>J.K.</given-names></name><name><surname>Wackett</surname><given-names>L.P.</given-names></name></person-group><article-title>Biosynthesis and chemical diversity of &#x003b2;-lactone natural products</article-title><source>Nat. Prod. Rep.</source><volume>36</volume><year>2019</year><fpage>458</fpage><lpage>475</lpage><pub-id pub-id-type="pmid">30191940</pub-id>
</element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Kaysser</surname><given-names>L.</given-names></name></person-group><article-title>Built to bind: biosynthetic strategies for the formation of small-molecule protease inhibitors</article-title><source>Nat. Prod. Rep.</source><volume>36</volume><year>2019</year><fpage>1654</fpage><lpage>1686</lpage><pub-id pub-id-type="pmid">30976762</pub-id>
</element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>F.</given-names></name><name><surname>Bauer</surname><given-names>J.S.</given-names></name><name><surname>Bendel</surname><given-names>T.M.</given-names></name><name><surname>Kulik</surname><given-names>A.</given-names></name><name><surname>Kalinowski</surname><given-names>J.</given-names></name><name><surname>Gross</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Biosynthesis of the &#x003b2;-lactone proteasome inhibitors belactosin and cystargolide</article-title><source>Angew. Chem. Int. Ed.</source><volume>56</volume><year>2017</year><fpage>6665</fpage><lpage>6668</lpage></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Medema</surname><given-names>M.H.</given-names></name><name><surname>Takano</surname><given-names>E.</given-names></name><name><surname>Breitling</surname><given-names>R.</given-names></name></person-group><article-title>Detecting sequence homology at the gene cluster level with MultiGeneBlast</article-title><source>Mol. Biol. Evol.</source><volume>30</volume><year>2013</year><fpage>1218</fpage><lpage>1223</lpage><pub-id pub-id-type="pmid">23412913</pub-id>
</element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Kouprina</surname><given-names>N.</given-names></name><name><surname>Larionov</surname><given-names>V.</given-names></name></person-group><article-title>Selective isolation of genomic loci from complex genomes by transformation-associated recombination cloning in the yeast <italic>Saccharomyces cerevisiae</italic></article-title><source>Nat. Protoc.</source><volume>3</volume><year>2008</year><fpage>371</fpage><pub-id pub-id-type="pmid">18323808</pub-id>
</element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Yamanaka</surname><given-names>K.</given-names></name><name><surname>Reynolds</surname><given-names>K.A.</given-names></name><name><surname>Kersten</surname><given-names>R.D.</given-names></name><name><surname>Ryan</surname><given-names>K.S.</given-names></name><name><surname>Gonzalez</surname><given-names>D.J.</given-names></name><name><surname>Nizet</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>111</volume><year>2014</year><fpage>1957</fpage><lpage>1962</lpage><pub-id pub-id-type="pmid">24449899</pub-id>
</element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Mill&#x000e1;n-Agui&#x000f1;aga</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>J.J.</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>E.C.</given-names></name><name><surname>Ugalde</surname><given-names>J.A.</given-names></name><etal/></person-group><article-title>Identification of thiotetronic acid antibiotic biosynthetic pathways by target-directed genome mining</article-title><source>ACS Chem. Biol.</source><volume>10</volume><year>2015</year><fpage>2841</fpage><lpage>2849</lpage><pub-id pub-id-type="pmid">26458099</pub-id>
</element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Gust</surname><given-names>B.</given-names></name><name><surname>Challis</surname><given-names>G.L.</given-names></name><name><surname>Fowler</surname><given-names>K.</given-names></name><name><surname>Kieser</surname><given-names>T.</given-names></name><name><surname>Chater</surname><given-names>K.F.</given-names></name></person-group><article-title>PCR-targeted Streptomyces gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>100</volume><year>2003</year><fpage>1541</fpage><lpage>1546</lpage><pub-id pub-id-type="pmid">12563033</pub-id>
</element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Bolhuis</surname><given-names>H.</given-names></name><name><surname>van Veen</surname><given-names>H.W.</given-names></name><name><surname>Poolman</surname><given-names>B.</given-names></name><name><surname>Driessen</surname><given-names>A.J.</given-names></name><name><surname>Konings</surname><given-names>W.N.</given-names></name></person-group><article-title>Mechanisms of multidrug transporters</article-title><source>FEMS Microbiol. Rev.</source><volume>21</volume><year>1997</year><fpage>55</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">9299702</pub-id>
</element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Garrido</surname><given-names>M.C.</given-names></name><name><surname>Herrero</surname><given-names>M.</given-names></name><name><surname>Kolter</surname><given-names>R.</given-names></name><name><surname>Moreno</surname><given-names>F.</given-names></name></person-group><article-title>The export of the DNA replication inhibitor Microcin B17 provides immunity for the host cell</article-title><source>EMBO J.</source><volume>7</volume><year>1988</year><fpage>1853</fpage><lpage>1862</lpage><pub-id pub-id-type="pmid">3049078</pub-id>
</element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Schell</surname><given-names>M.A.</given-names></name></person-group><article-title>Molecular biology of the LysR family of transcriptional regulators</article-title><source>Annu. Rev. Microbiol.</source><volume>47</volume><year>1993</year><fpage>597</fpage><lpage>626</lpage><pub-id pub-id-type="pmid">8257110</pub-id>
</element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Fawaz</surname><given-names>M.V.</given-names></name><name><surname>Topper</surname><given-names>M.E.</given-names></name><name><surname>Firestine</surname><given-names>S.M.</given-names></name></person-group><article-title>The ATP-grasp enzymes</article-title><source>Bioorg. Chem.</source><volume>39</volume><year>2011</year><fpage>185</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">21920581</pub-id>
</element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Baulig</surname><given-names>A.</given-names></name><name><surname>Helmle</surname><given-names>I.</given-names></name><name><surname>Bader</surname><given-names>M.</given-names></name><name><surname>Wolf</surname><given-names>F.</given-names></name><name><surname>Kulik</surname><given-names>A.</given-names></name><name><surname>Al-Dilaimi</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Biosynthetic reconstitution of deoxysugar phosphoramidate metalloprotease inhibitors using an N&#x02013;P-bond-forming kinase</article-title><source>Chem. Sci.</source><volume>10</volume><year>2019</year><fpage>4486</fpage><lpage>4490</lpage><pub-id pub-id-type="pmid">31057776</pub-id>
</element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Quitterer</surname><given-names>F.</given-names></name><name><surname>List</surname><given-names>A.</given-names></name><name><surname>Beck</surname><given-names>P.</given-names></name><name><surname>Bacher</surname><given-names>A.</given-names></name><name><surname>Groll</surname><given-names>M.</given-names></name></person-group><article-title>Biosynthesis of the 22nd genetically encoded amino acid pyrrolysine: structure and reaction mechanism of PylC at 1.5A resolution</article-title><source>J.&#x000a0;Mol. Biol.</source><volume>424</volume><year>2012</year><fpage>270</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">22985965</pub-id>
</element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Shimo</surname><given-names>S.</given-names></name><name><surname>Ushimaru</surname><given-names>R.</given-names></name><name><surname>Engelbrecht</surname><given-names>A.</given-names></name><name><surname>Harada</surname><given-names>M.</given-names></name><name><surname>Miyamoto</surname><given-names>K.</given-names></name><name><surname>Kulik</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Stereodivergent nitrocyclopropane formation during biosynthesis of belactosins and hormaomycins</article-title><source>J.&#x000a0;Am. Chem. Soc.</source><volume>143</volume><year>2021</year><fpage>18413</fpage><lpage>18418</lpage><pub-id pub-id-type="pmid">34710328</pub-id>
</element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Engelbrecht</surname><given-names>A.</given-names></name><name><surname>Wolf</surname><given-names>F.</given-names></name><name><surname>Esch</surname><given-names>A.</given-names></name><name><surname>Kulik</surname><given-names>A.</given-names></name><name><surname>Kozhushkov</surname><given-names>S.I.</given-names></name><name><surname>de Meijere</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Discovery of a cryptic nitro intermediate in the biosynthesis of the 3-(trans-2'-Aminocyclopropyl)alanine moiety of belactosin A</article-title><source>Org. Lett.</source><volume>24</volume><year>2022</year><fpage>736</fpage><lpage>740</lpage><pub-id pub-id-type="pmid">34990553</pub-id>
</element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>A.A.</given-names></name><name><surname>Chee</surname><given-names>S.H.</given-names></name><name><surname>Stocker</surname><given-names>B.L.</given-names></name><name><surname>Timmer</surname><given-names>M.S.</given-names></name></person-group><article-title>The synthesis of long-chain &#x003b1;-Alkyl-&#x003b2;-Hydroxy esters using allylic halides in a Fr&#x000e1;ter&#x02013;seebach alkylation</article-title><source>Eur. J. Org. Chem.</source><volume>5</volume><year>2012</year><fpage>995</fpage><lpage>1002</lpage></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>de Meijere</surname><given-names>A.</given-names></name><name><surname>Korotkov</surname><given-names>V.S.</given-names></name><name><surname>Lygin</surname><given-names>A.V.</given-names></name><name><surname>Larionov</surname><given-names>O.V.</given-names></name><name><surname>Sokolov</surname><given-names>V.V.</given-names></name><name><surname>Graef</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Synthesis and biological activity of simplified belactosin C analogues</article-title><source>Org. Biomol. Chem.</source><volume>10</volume><year>2012</year><fpage>6363</fpage><lpage>6374</lpage><pub-id pub-id-type="pmid">22735304</pub-id>
</element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>S.</given-names></name><name><surname>Hanson</surname><given-names>R.E.</given-names></name><name><surname>Cronan</surname><given-names>J.E.</given-names></name></person-group><article-title>Biotin synthesis begins by hijacking the fatty acid synthetic pathway</article-title><source>Nat. Chem. Biol.</source><volume>6</volume><year>2010</year><fpage>682</fpage><lpage>688</lpage><pub-id pub-id-type="pmid">20693992</pub-id>
</element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="book" id="sref34"><person-group person-group-type="author"><name><surname>Kieser</surname><given-names>T.</given-names></name><name><surname>Bibb</surname><given-names>M.</given-names></name><name><surname>Buttner</surname><given-names>M.</given-names></name><name><surname>Chater</surname><given-names>K.</given-names></name><name><surname>Hopwood</surname><given-names>D.</given-names></name></person-group><part-title>Practical Streptomyces Genetics</part-title><year>2000</year><publisher-name>The John Innes Foundation</publisher-name><publisher-loc>Norwich, UK</publisher-loc></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="book" id="sref35"><person-group person-group-type="author"><name><surname>Sambrook</surname><given-names>J.</given-names></name><name><surname>Russell</surname><given-names>D.W.</given-names></name></person-group><part-title>Molecular Cloning. A Laboratory Manual</part-title><year>2001</year><publisher-name>Cold Spring Harbor Laboratory Press</publisher-name><publisher-loc>New York</publisher-loc></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Datsenko</surname><given-names>K.A.</given-names></name><name><surname>Wanner</surname><given-names>B.L.</given-names></name></person-group><article-title>One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>97</volume><year>2000</year><fpage>6640</fpage><lpage>6645</lpage><pub-id pub-id-type="pmid">10829079</pub-id>
</element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Cherepanov</surname><given-names>P.P.</given-names></name><name><surname>Wackernagel</surname><given-names>W.</given-names></name></person-group><article-title>Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant</article-title><source>Gene</source><volume>158</volume><year>1995</year><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">7789817</pub-id>
</element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>MacNeil</surname><given-names>D.J.</given-names></name><name><surname>Gewain</surname><given-names>K.M.</given-names></name><name><surname>Ruby</surname><given-names>C.L.</given-names></name><name><surname>Dezeny</surname><given-names>G.</given-names></name><name><surname>Gibbons</surname><given-names>P.H.</given-names></name><name><surname>MacNeil</surname><given-names>T.</given-names></name></person-group><article-title>Analysis of Streptomyces avermitilis genes required for avermectin biosynthesis utilizing a novel integration vector</article-title><source>Gene</source><volume>111</volume><year>1992</year><fpage>61</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">1547955</pub-id>
</element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Flett</surname><given-names>F.</given-names></name><name><surname>Mersinias</surname><given-names>V.</given-names></name><name><surname>Smith</surname><given-names>C.P.</given-names></name></person-group><article-title>High efficiency intergeneric conjugal transfer of plasmid DNA from Escherichia coli to methyl DNA-restricting streptomycetes</article-title><source>FEMS Microbiol. Lett.</source><volume>155</volume><year>2006</year><fpage>223</fpage><lpage>229</lpage></element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Zettler</surname><given-names>J.</given-names></name><name><surname>Xia</surname><given-names>H.</given-names></name><name><surname>Burkard</surname><given-names>N.</given-names></name><name><surname>Kulik</surname><given-names>A.</given-names></name><name><surname>Grond</surname><given-names>S.</given-names></name><name><surname>Heide</surname><given-names>L.</given-names></name><etal/></person-group><article-title>New aminocoumarins from the rare actinomycete Catenulispora acidiphila DSM 44928: identification, structure elucidation, and heterologous production</article-title><source>Chembiochem</source><volume>15</volume><year>2014</year><fpage>612</fpage><lpage>621</lpage><pub-id pub-id-type="pmid">24554531</pub-id>
</element-citation></ref></ref-list><sec id="appsec1" sec-type="supplementary-material"><title>Supporting information</title><p id="p0195">
<supplementary-material content-type="local-data" id="mmc1"><caption><title>Supporting Figures&#x000a0;and Tables</title></caption><media xlink:href="mmc1.pdf"/></supplementary-material>
</p></sec><ack id="ack0010"><sec id="sec6"><title>Author contribution</title><p id="p0185">P. B., P. F., F. W., D. M., I. H., D. U., A. E., W. K., N. D. S., and A. K. investigation; P. B. writing &#x02013; original draft; F. W. and N. D. S. formal analysis; F. W., D. M., W. K. and N. D. S. methodology; A. E. validation; H. G. and L. K. conceptualization; H. G. and M. G. data curation; H. G., M. G. and L. K. supervision; L. K. writing &#x02013; reviewing and editing.</p></sec><sec id="sec7"><title>Funding and additional information</title><p id="p0190">This work was funded by the <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source> (German Research Foundation, DFG) TRR 261, project-ID No. 398967434-TRR 261, GRK1708 (L. K and A. E.), <funding-source id="gs4"><institution-wrap><institution-id institution-id-type="doi">10.13039/100004807</institution-id><institution>DFG</institution></institution-wrap></funding-source>-SFB 1309&#x02013;325871075 (W. K. and M. G.) as well as KA 3071/4-1 (L. K. and F. W.) and KA 3071/6-1 (L. K. and P. B.). N. D. S. and L. K. were also supported by the <funding-source id="gs5">Institutional Strategy of the University of T&#x000fc;bingen</funding-source> (DFG, ZUK 63). Publication was funded by the Open Access Publishing Fund of Leipzig University supported by the German Research Foundation within the program Open Access Publication Funding.</p></sec></ack></back></article>